Psilera Appoints Neuroscience Veteran Allyson Gage, PhD, as Vice President, Clinical Development to Lead Upcoming Phase 1 Clinical Trial

Phase 1PSIL-006Positive

AI Analysis

Summary

Psilera appoints neuroscience veteran Allyson Gage, PhD as Vice President of Clinical Development to lead the upcoming Phase 1 clinical trial of its lead neuroplastogen PSIL-006.

Clinical Trial Data

Phase

Phase 1

Importance:3/10

Sentiment:

0.30

clinical developmentneuroplastogenPhase 1leadership appointment

Related Companies

$GBIO

Read the original article

Published by PR Newswire Biotech on August 27, 2026 12:15 PM

Read Original